167 related articles for article (PubMed ID: 16510459)
1. Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease.
Beecroft J; Duffin J; Pierratos A; Chan CT; McFarlane P; Hanly PJ
Eur Respir J; 2006 Jul; 28(1):151-8. PubMed ID: 16510459
[TBL] [Abstract][Full Text] [Related]
2. Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease.
Beecroft JM; Zaltzman J; Prasad R; Meliton G; Hanly PJ
Nephrol Dial Transplant; 2007 Oct; 22(10):3028-33. PubMed ID: 17556419
[TBL] [Abstract][Full Text] [Related]
3. Decreased chemosensitivity and improvement of sleep apnea by nocturnal hemodialysis.
Beecroft JM; Duffin J; Pierratos A; Chan CT; McFarlane P; Hanly PJ
Sleep Med; 2009 Jan; 10(1):47-54. PubMed ID: 18226958
[TBL] [Abstract][Full Text] [Related]
4. Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea.
Beecroft JM; Hoffstein V; Pierratos A; Chan CT; McFarlane PA; Hanly PJ
Eur Respir J; 2007 Nov; 30(5):965-71. PubMed ID: 17626107
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease.
Beecroft JM; Hoffstein V; Pierratos A; Chan CT; McFarlane P; Hanly PJ
Nephrol Dial Transplant; 2008 Feb; 23(2):673-9. PubMed ID: 17890744
[TBL] [Abstract][Full Text] [Related]
6. Overnight changes of chemoreflex control in obstructive sleep apnoea patients.
Mahamed S; Hanly PJ; Gabor J; Beecroft J; Duffin J
Respir Physiol Neurobiol; 2005 Apr; 146(2-3):279-90. PubMed ID: 15766916
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ResMed AutoSet (version 3.03) with polysomnography in the diagnosis of the sleep apnoea/hypopnoea syndrome.
Gugger M
Eur Respir J; 1997 Mar; 10(3):587-91. PubMed ID: 9072989
[TBL] [Abstract][Full Text] [Related]
8. The effect of fluid overload on sleep apnoea severity in haemodialysis patients.
Lyons OD; Inami T; Perger E; Yadollahi A; Chan CT; Bradley TD
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28381432
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea.
Resta O; Foschino-Barbaro MP; Bonfitto P; Talamo S; Legari G; De Pergola G; Minenna A; Giorgino R
Respir Med; 2000 Mar; 94(3):240-6. PubMed ID: 10783935
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hypertension and circadian blood pressure variations in patients with obstructive sleep apnoea-hypopnoea syndrome.
Wang Y; Li C; Feng L; Feng J; Cao J; Chen B
J Int Med Res; 2014 Jun; 42(3):773-80. PubMed ID: 24651995
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness.
Wang D; Marshall NS; Duffin J; Yee BJ; Wong KK; Noori N; Ng SS; Grunstein RR
J Sleep Res; 2011 Dec; 20(4):526-32. PubMed ID: 21668806
[TBL] [Abstract][Full Text] [Related]
12. Chemoreflexes--physiology and clinical implications.
Kara T; Narkiewicz K; Somers VK
Acta Physiol Scand; 2003 Mar; 177(3):377-84. PubMed ID: 12609009
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension.
Kasai T; Bradley TD; Friedman O; Logan AG
J Hypertens; 2014 Mar; 32(3):673-80. PubMed ID: 24284499
[TBL] [Abstract][Full Text] [Related]
14. Upper airway function and arousability to ventilatory challenge in slow wave versus stage 2 sleep in obstructive sleep apnoea.
Ratnavadivel R; Stadler D; Windler S; Bradley J; Paul D; McEvoy RD; Catcheside PG
Thorax; 2010 Feb; 65(2):107-12. PubMed ID: 19850964
[TBL] [Abstract][Full Text] [Related]
15. Ventilatory control in patients with sleep apnoea and left ventricular dysfunction: comparison of obstructive and central sleep apnoea.
Wilcox I; McNamara SG; Dodd MJ; Sullivan CE
Eur Respir J; 1998 Jan; 11(1):7-13. PubMed ID: 9543263
[TBL] [Abstract][Full Text] [Related]
16. Respiratory responses to chemical stimulation in patients with obstructive sleep apnoea.
Radwan L; Maszczyk Z; Koziej M; Franczuk M; Koziorowski A; Kowalski J; Zieliński J
Monaldi Arch Chest Dis; 2000 Apr; 55(2):96-100. PubMed ID: 10949866
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment with nasal continuous positive airway pressure on ventilatory response to hypoxia and hypercapnia in patients with sleep apnea syndrome.
Spicuzza L; Bernardi L; Balsamo R; Ciancio N; Polosa R; Di Maria G
Chest; 2006 Sep; 130(3):774-9. PubMed ID: 16963674
[TBL] [Abstract][Full Text] [Related]
18. Differential impact of body position on the severity of disordered breathing in heart failure patients with obstructive vs. central sleep apnoea.
Pinna GD; Robbi E; La Rovere MT; Taurino AE; Bruschi C; Guazzotti G; Maestri R
Eur J Heart Fail; 2015 Dec; 17(12):1302-9. PubMed ID: 26467056
[TBL] [Abstract][Full Text] [Related]
19. Sleep apnoea is common in severe peripheral arterial disease.
Schahab N; Sudan S; Schaefer C; Tiyerili V; Steinmetz M; Nickenig G; Skowasch D; Pizarro C
PLoS One; 2017; 12(7):e0181733. PubMed ID: 28759652
[TBL] [Abstract][Full Text] [Related]
20. Assessment of sleep-disordered breathing using a non-contact bio-motion sensor.
Zaffaroni A; Kent B; O'Hare E; Heneghan C; Boyle P; O'Connell G; Pallin M; de Chazal P; McNicholas WT
J Sleep Res; 2013 Apr; 22(2):231-6. PubMed ID: 23176607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
